3659 results for «700»

Filter By

3659 results

Percutaneous management of mitral and aortic valve disease

21 May 2026 – From EuroPCR 2026

Delve into the percutaneous management of mitral and aortic valve disease through detailed procedural demonstrations. This session covers valve-in-valve procedures, navigation of potential complications in valve-in-valve TAVI, and mitral valve edge-to-edge repair techniques, supported by real-world case discussions and key learnings.

Complex multivessel disease: from calcium to physiology - Case-based decisions

21 May 2026 – From EuroPCR 2026

Focus on complex multivessel coronary artery disease management with an emphasis on severely calcified lesions and the integration of intracoronary imaging and physiology. This session prepares clinicians to anticipate and manage complications during PCI, enhancing competence in treating challenging coronary anatomies through case-based decision-making.

Insight from new evidence for complex PCI: value of imaging (CHIP IVUS) and left ventricular support (CHIP BCIS 3)

21 May 2026 – From EuroPCR 2026

This session reviews the impact of recent evidence on complex PCI, highlighting the value of intracoronary imaging (CHIP IVUS trial) and left ventricular assist devices (CHIP BCIS 3 trial). Through case discussions, participants reflect on how these innovations influence daily clinical practice and enhance procedural planning...

Left main interventions: pushing the boundaries

21 May 2026 – From EuroPCR 2026

Examine contemporary strategies for distal left main bifurcation disease treatment, including debates on complex bifurcation and high-risk PCI approaches. The session emphasizes the critical role of coronary imaging in guiding decision-making and showcases clinical cases illustrating management of left main interventions under challenging conditions.

Challenging procedures for bifurcation lesions

22 May 2026 – From EuroPCR 2026

Explore a series of challenging cases in coronary bifurcation interventions, highlighting complex decision-making scenarios, pharmaco-invasive strategies guided by IVUS, and tailored techniques for reintervention. Emphasis is placed on imaging-guided PCI and simplifying complex double bifurcation and long lesion treatments to optimize patient outcomes.

Beyond stent: use of DCB in CTO

22 May 2026 – From EuroPCR 2026

This session focuses on the innovative use of drug-coated balloons (DCB) in chronic total occlusion (CTO) interventions. It reviews combined plaque modification techniques, complex multivessel PCI cases involving CTOs, and strategy considerations such as hybrid therapy versus full metal jacket, emphasizing vessel biology preservation during revascularisation.

TAVI and Coronary access

11 Dec 2019

Watch the video on demand with Lars Sondergaard, Giuseppe Tarantini and Thierry Lefevre

PCR Webinar Round Table on TAVI and Coronary access

TAVI in bicuspid aortic valve disease

26 Nov 2019

Watch the video on demand with leading experts Bernard Prendergast, Markus Kasel and Won-Keun Kim

View the replay of this PCR Webinar on TAVI in bicuspid aortic valve disease

Spotlight on a selection of top Late-breaking Trials presented at PCR London Valves 2025

17 Nov 2025

View a snapshot of the results of these 4 trials in valvular and structural interventions presented in London during this year's Heart Team Course!

Selection of top Late-breaking Trials presented at #PCRLV

REVIVED-BCIS2: no benefit of routine PCI in patients with reduced LVEF

13 Mar 2023

Dejan Milasinovic provides his take on the REVIVED trial - percutaneous revascularisation for ischaemic ventricular dysfunction, which was presented during ESC Congress 2022 in Barcelona.

Dejan Milasinovic

Author

Dejan Milasinovic
REVIVED - Percutaneous Revascularisation for Ischaemic Ventricular Dysfunction

PARTNERS IN LEARNING – MAIN ARENA LIVE CASE SESSION EuroPCR 2023

16 May 2023

Paris, France, 16 May 2023. Within 20 years of its first appearance on the clinical stage, transfemoral transcatheter aortic valve implantation (TF-TAVI) has become an established treatment option for patients with symptomatic severe aortic stenosis (AS) that is supported by Class IA recommendations in current European and...

Partners in learning - Main Arena LIVE Case session EuroPCR 2023

Predicting the unpredictable: application of predictive modeling in complex transcatheter aortic valve replacement

13 Dec 2023

This case highlights the potential add-on value of reduced-order computational modeling over standard CT scan analysis due to its ability to predict the interaction of different devices or sizes with the patient-specific anatomy.

Predicting the unpredictable: application of predictive modeling in complex transcatheter aortic valve replacement

MedAlliance acquired by Cordis for up to USD 1.135 billion

02 Oct 2023

In Person in Paris and online EuroPCR 2022 celebrates the best of both worlds

09 May 2022

EuroPCR is celebrating being back home in Paris, in-person, for the first time in 3 years. This year’s international Course will see both a complete on-site programme and a full digital experience, bringing the community together to share and learn.

In Person in Paris and online EuroPCR 2022 celebrates the best of both worlds

Worldwide Emergency Medical Services to receive the Andreas Grüntzig Ethica Award at EuroPCR 2023

16 May 2023

Paris, France. At EuroPCR 2023, the interventional community paid tribute to Emergency Medical Services throughout the world for their critical role in enabling timely care. International representatives of emergency medical services received the Andreas Grüntzig Ethica Award at the opening ceremony of this year’s Course, further...

Worldwide Emergency Medical Services to receive the Andreas Grüntzig Ethica Award at EuroPCR 2023

Interventions with drug-coated balloons – a PCR Statement

18 May 2023

Paris, France, 17 May 2023.  The field of coronary drug-coated balloon (DCB) angioplasty looks set to assume growing importance in the years to come and the potential for increased use of these devices in clinical practice is considerable.

Interventions with drug-coated balloons – a PCR Statement

EuroPCR 2023 – The interventional cardiovascular community is gathering in Paris to learn, share, and shape the future of patient care worldwide

15 May 2023

EuroPCR, the annual world-leading Course in interventional cardiovascular medicine, has been taking place for over 30 years. It is tailored for all those dedicated to the sharing of knowledge and skills, and improvement of patient care worldwide: interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, allied...

EuroPCR 2023 – The interventional cardiovascular community is gathering in Paris

EuroPCR 2021 - Unprecedented global outreach and online interactivity during an innovative livestreamed edition

25 May 2021

Paris, France. 21 May 2021.  Since 1989, EuroPCR has constantly pioneered innovative educational tools and formats to help the interventional cardiovascular community effectively share their knowledge, skills and practice. Rising up to the challenge of the pandemic, the 31st annual edition was fundamentally rethought, reshaped and...

EuroPCR 2021

UNIVERSAL: routine ultrasonography guidance for femoral vascular access for cardiac procedures - A randomized clinical Trial

19 Sep 2022

Ali Nazmi Calik provides his take on UNIVERSAL randomized clinical trial, which questioned whether routine ultrasonography guidance for CFA access for cardiac procedures reduces bleeding or vascular complications. This trial was presented by Sanjit S. Jolly during TCT 2022.

Ali Nazmi Calik

Author

Ali Nazmi Calik
UNIVERSAL: routine ultrasonography guidance for femoral vascular access for cardiac procedures - A randomized clinical Trial
Didn’t find what you were looking for?